Kings College Hospital Wins Clinical Excellence Award for Use of
Laserscope's GreenLight PVP Procedure

Wednesday November 3, 7:01 am ET

United Kingdom's National Health Services Recognizes Patient Benefits and
Cost-Effectiveness of PVP

SAN JOSE, Calif., Nov. 3 /PRNewswire-FirstCall/ -- Laserscope (Nasdaq:
LSCP - News), a pioneer in the development and commercialization of medical
lasers and advanced fiber-optic devices, today announced that based on the
use of its GreenLight PVP(TM) procedure for the treatment of Benign
Prostatic Hyperplasia (BPH), Kings College Hospital NHS Trust, a leading
London-based healthcare facility, won a prestigious clinical excellence
innovation award from the Modernisation Agency of the United Kingdom's
socialized medicine body, or National Health Service (NHS).
Kings College Hospital demonstrated that by performing Laserscope's PVP
procedure on an outpatient basis, versus conducting the more invasive
trans-urethral resection of the prostate, or TURP, procedure, the hospital
was able to reduce costs and waiting times while increasing patient
satisfaction and experience. In the UK, TURP generally involves long
hospital stays, long waiting lists and high morbidity.

"We are very excited and encouraged by the work being done by Dr. Gordon
Muir and his staff and colleagues at Kings College Hospital," said Eric
Reuter, President and Chief Executive Officer of Laserscope. "By utilizing
our innovative PVP procedure to treat BPH, the hospital has clearly
demonstrated the clinical efficacy and many other important benefits of PVP
versus other more invasive, more costly and less effective treatment
options.

"We have had considerable success in the UK's private healthcare sector
since launching our GreenLight system in 2002, but penetrating the
two-tiered health-care system in the UK, as in many other countries, remains
a challenge in that not only must clinical efficacy be demonstrated, but
also the cost-effectiveness of the procedure as well," said Mr. Reuter.

"We believe that the recognition and visibility Laserscope is receiving from
this NHS award being granted to a world-renowned medical center such as
Kings College, will help us gain a higher level of visibility and
credibility for the many positive attributes of PVP, not only within the
UK's public healthcare system, but in other two-tiered health-care systems
around the globe. This brings us even closer to our top priority -- ensuring
that Laserscope's GreenLight PVP, or Photo-Selective Vaporization of the
Prostate, is recognized as the new worldwide standard of care for treating
BPH."